Pregnancy and antibodies to phospholipids.

di Walport, M J
Pubblicazione 1989

Respiration and connective tissue diseases.

di Walport, M J
Pubblicazione 1987

Methods in Complement for Clinical Immunologists

di Walport, M. J.
Pubblicazione 1986

Antiphospholipid antibodies and cardiovascular disease.

di Beynon, H L, Walport, M J
Pubblicazione 1992

Giant cell arteritis.

di Mason, J. C., Walport, M. J.
Pubblicazione 1992

The rate of loss of CR1 from ageing erythrocytes in vivo in normal subjects and SLE patients: no correlation with structural or numerical polymorphisms.

di Moldenhauer, F, Botto, M, Walport, M J
Pubblicazione 1988

Effects of C4 null alleles and homoduplications on quantitative expression of C4A and C4B.

di Hammond, A, Ollier, W, Walport, M J
Pubblicazione 1992

Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder.

di Mackworth-Young, C G, Loizou, S, Walport, M J
Pubblicazione 1989

Sulphasalazine and regression of rheumatoid nodules.

di Englert, H J, Hughes, G R, Walport, M J
Pubblicazione 1987

Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.

di Ng, Y C, Schifferli, J A, Walport, M J
Pubblicazione 1988

Immunoglobulin class and IgG subclass distribution of anticardiolipin antibodies in patients with systemic lupus erythematosus and associated disorders.

di Loizou, S, Cofiner, C, Weetman, A P, Walport, M J
Pubblicazione 1992

Long-term management after splenectomy. Consider prophylaxis in systematic lupus erythematosus.

di Davies, K. A., Beynon, H. L., Walport, M. J.
Pubblicazione 1994

Reversal of aplastic anaemia secondary to systemic lupus erythematosus by high-dose intravenous cyclophosphamide

di Walport, M J, Hubbard, W N, Hughes, G R V
Pubblicazione 1982

Heterogeneity of binding reactivity to different phospholipids of antibodies from patients with systemic lupus erythematosus (SLE) and with syphilis.

di Loizou, S, Mackworth-Young, C G, Cofiner, C, Walport, M J
Pubblicazione 1990

Expression of MHC class I determinants on erythrocytes of SLE patients.

di Giles, C M, Walport, M J, David, J, Darke, C
Pubblicazione 1987

Identification and partial characterization of an exercise-induced neutrophil chemotactic factor in bronchial asthma.

di Lee, T H, Nagy, L, Nagakura, T, Walport, M J, Kay, A B
Pubblicazione 1982

Immune complex processing in patients with systemic lupus erythematosus. In vivo imaging and clearance studies.

di Davies, K A, Peters, A M, Beynon, H L, Walport, M J
Pubblicazione 1992

The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.

di Schifferli, J A, Ng, Y C, Paccaud, J P, Walport, M J
Pubblicazione 1989

A lysine-binding protein in SLE sera inhibits the binding of immune complexes to normal erythrocyte CR1 (complement receptor type 1).

di Ng, Y C, Peters, D K, Cederholm-Williams, S A, Walport, M J
Pubblicazione 1987

Reduction in T gamma delta cell numbers and alteration in subset distribution in systemic lupus erythematosus.

di Lunardi, C, Marguerie, C, Bowness, P, Walport, M J, So, A K
Pubblicazione 1991